Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin vs Placebo in Closed Loop for T1DM
NCT02328040Phase 1Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Sep 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Placebo + Insulin with Sitagliptin + Insulin (2 arms). Primary endpoint: Blood Glucose Measures (Area Under the Curve) at 18 months. Started Sep 2014; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02328040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02328040.